Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
A Randomized Controlled Trial of Diet & Exercise Interventions Among Men With Prostate Cancer - II (Prostate 8-II)
3 other identifiers
interventional
204
1 country
1
Brief Summary
The Prostate 8-II study is a randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable prostate-cancer
Started May 2018
Longer than P75 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2018
CompletedFirst Submitted
Initial submission to the registry
June 21, 2019
CompletedFirst Posted
Study publicly available on registry
June 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
July 16, 2026
July 1, 2026
10.3 years
June 21, 2019
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Median Time to prostate-specific antigen recurrence
The median time in months to PSA recurrence after surgery will be evaluated using prespecified biochemical recurrence (2x PSA ≥ 0.2) and detectable (2x PSA ≥ 0.03) PSA thresholds, at the time of analysis. A log-rank test to evaluate the time to recurrence among groups and multivariate Cox proportional hazards regression will be used to obtain a hazard ratio for the time to recurrence.
Up to 5 years post-surgery
Secondary Outcomes (12)
Proportion of participants with PSA recurrence over time
Up to 24 months post-surgery
Mean scores on the Expanded Prostate Cancer Index Composite Short Form (EPIC-26) over time.
Baseline, and 6 months, 12 months, and 24 months post-surgery
Mean scores on the urinary function domain of the EPIC-26 over time.
Baseline, and 6 months, 12 months, and 24 months post-surgery
Mean scores on the general anxiety scale of the Patient-Reported Outcomes Measurement Information System (PROMIS) over time.
Baseline, and 6 months, 12 months, and 24 months post-surgery
Mean scores on the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) over time.
Baseline, and 6 months, 12 months, and 24 months post-surgery
- +7 more secondary outcomes
Study Arms (4)
Arm A: Reference Group
ACTIVE COMPARATORArm A will receive print educational materials about the benefits of exercise and diet for men with prostate cancer, with recommendations geared at men living with prostate cancer, mailed around the date of surgery. They also receive a 10-week text messaging program focused on recovery after radical prostatectomy surgery.
Arm B (Arm A + Exercise)
EXPERIMENTALArm B receives the following: Arm A material plus access to an online portal with additional educational materials to help improve exercise habits and various tools, such as the ability to track exercise; additional educational print materials on exercise; additional text messages over 2 years that supports healthy exercise habits; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with an exercise coach over 2 years.
Arm C (Arm A + Diet)
EXPERIMENTALArm C receives the following: Arm A material plus access to an online portal with additional educational materials to help improve diet habits and various tools, such as the ability to track diet; additional educational print materials on diet; additional text messages over 2 years that supports healthy diet habits; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with a diet coach over 2 years.
Arm D (Arm A + Exercise + Diet)
EXPERIMENTALArm D receives the following: Arm A material plus access to an online portal with additional educational materials to help improve exercise and diet habits and various tools, such as the ability to track exercise and diet; additional educational print materials on exercise and diet; additional text messages over 2 years that supports healthy exercise and diet habits; a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with an exercise coach over 2 years; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with a diet coach over 2 years.
Interventions
Behavioral program provides access to educational materials + clinical texting program (Arm A) + participant portal, text messaging, and coaching (Arms B-D)
Eligibility Criteria
You may qualify if:
- Age \>=18 years
- Diagnosed with non-metastatic prostate cancer and choose radical prostatectomy (RP) as primary treatment.
- Able to speak and read English
- Regular access to the Internet (via a computer, tablet, or phone) and text messaging capabilities on the phone
- Ability to understand a written informed consent document, and the willingness to sign it
You may not qualify if:
- Cannot have neoadjuvant radiation or hormone therapy planned at time of enrollment (if enrolling \>4 weeks prior to RP).
- Men who have contraindications to exercise based the American College of Sports Medicine 2016 Exercise pre-participation screening criteria (https://www.ncbi.nlm.nih.gov/pubmed/26473759), and who do not receive a physician clearance to participate in the moderate to vigorous intensity physical activity with one or more of the following self-reported conditions:
- Heart attack
- Heart surgery, cardiac catheterization, or coronary angioplasty
- Pacemaker/implantable cardiac defibrillator/rhythm disturbance
- Heart valve disease
- Heart failure
- Heart transplantation
- Congenital heart disease
- Diabetes
- Kidney (renal) disease
- Chest discomfort with exertion
- Unreasonable breathlessness
- Dizziness, fainting, or blackouts
- Ankle swelling
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacey A Kenfield, DSc
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2019
First Posted
June 26, 2019
Study Start
May 11, 2018
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share